12.10.2014 Views

UBI Banca Group

UBI Banca Group

UBI Banca Group

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

elation to higher volumes of business), +€2.6 million from “current account administration”<br />

and +€32.7 million from “other services” (which include commitment fees) 5 ;<br />

• management, trading and advisory services 6 , on the other hand, decreased by €53.4 million<br />

to €528.1 million (accounting for 44.2% of total net commission income compared to 49.1%<br />

before). The change is the aggregate result on the one hand of an increase in portfolio<br />

management commissions (+€4 million, the result, amongst other things, of a realignment<br />

of commissions on collective asset management instruments) and on the other hand of falls<br />

in the following items: placement of securities (-€30.5 million, in relation to lower orders for<br />

“third party securities”); distribution of insurance products (-€8.2 million); depository<br />

banking (-€7.7 million following the contribution of these operations in May 2010); receipt<br />

of orders and investment advisory services (-€3.9 million, as volatility on markets increased<br />

and customers adopted a prudent approach).<br />

A reduction in commission expense also occurred in relation to the distribution of financial<br />

instruments, products and services through indirect networks (-€8 million), due largely to<br />

the rationalisation of <strong>UBI</strong> <strong>Banca</strong> Lombarda Private Investment’s network of financial<br />

advisors.<br />

Even net of performance fees 7 (relating entirely to <strong>UBI</strong> Pramerica SGR and recognised in the<br />

fourth quarter, amounting to €11.7 million in 2011, compared to €15.4 million in 2010),<br />

quarterly net commission income held up well compared to previous interim periods and<br />

totalled €303.4 million (€292 million in the third quarter of 2011, €294.6 million in the second<br />

quarter and €291.9 million in the first). Changes within the item partially replicated annual<br />

trends and more specifically a comparison with the third quarter shows the following: an<br />

improvement in income from securities (+€3.1 million, attributable partly to customer portfolio<br />

managements, but above all to the distribution of insurance products, in the presence of lower<br />

securities brokerage and trading income) accompanied by good performance from<br />

commissions of a strictly banking nature (+€7.8 million).<br />

The performance during the year of assets classified under the fair value option affected the<br />

net result for financial activities, which was €7.3 million, compared to €34 million in 2010. In<br />

detail:<br />

• trading activities generated €10.7 million, compared to a loss previously of -€56.9 million,<br />

due almost entirely to the unwinding and ineffectiveness of hedging derivatives, used on a<br />

macro-hedge basis, for fixed rate mortgages subject to either early repayment or<br />

renegotiation. It is a phenomenon which had a greater impact in 2010 and which reduced<br />

considerably in 2011.<br />

Net of that unwinding phenomenon (-€18.4 million in 2011 and -€55.8 million in 2010),<br />

normal activities generated the following: +€26.4 million (-€14.6 million) from debt<br />

instruments (inclusive of financial liabilities held for trading) and the related derivative<br />

instruments; -€15.9 million (-€2.7 million) from equity instruments and the related<br />

derivative instruments, which incorporates the impairment loss on Medinvest International 8<br />

of €12.2 million; -€0.3 million (+€0.4 million) from investments in hedge funds; and +€13.7<br />

million (+€14.7 million) from foreign currency business;<br />

• the result for financial assets and liabilities at fair value – a loss of €38.8 million, compared<br />

to a profit of €6.7 million in 2010 – incorporated disposals of <strong>UBI</strong> Pramerica funds in the<br />

third quarter with a loss of €22 million, when a stop-loss 9 mechanism was triggered (in<br />

compliance with the limits set by the Financial Risks Policy) losses on Tages hedge funds,<br />

formerly Capitalgest (-€11.4 million) and the fair valuation of residual positions in other<br />

hedge funds;<br />

5 All the changes were calculated by subtracting commission expense from the respective commission income.<br />

6 The amount consists of management, trading and advisory services net of the corresponding expense items and is calculated<br />

excluding currency trading.<br />

7 The item accounts for 1% of total net commission income compared to 1.3% before.<br />

8 Medinvest International Sca (Luxembourg), classified within private equity investments and in which a 19.57% interest is held, is a<br />

merchant bank which invests in companies and also provides financial advisory services to SMEs. The impairment loss was<br />

recognised in relation to the poor performance of the main investment held in its portfolio.<br />

9 The losses incurred on the mutual fund portfolio caused <strong>UBI</strong> Pramerica SGR to firstly change the composition of the mix of products<br />

used for the Parent’s investments, with preference given to strictly monetary funds and then, in consideration of the continuing<br />

adverse conditions on markets, to sell all units held in funds at the end of September (€329.3 million as at 30 th June 2011).<br />

93

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!